Regardless, these results provide evidence of the relevance of CBX2/7 in predicting sensitivity to anticancer drugs and suggest that CBX2High breast tumors may be more likely to benefit from methotrexate and rapamycin treatment. The gene discussed is CBX2; the disease is breast neoplasm.